Non‐inferiority of microencapsulated mesenchymal stem cells to free cells in cardiac repair after myocardial infarction: A rationale for using paracrine factor(s) instead of cells
- 24 April 2019
- journal article
- research article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 100 (2) , 102-113
Abstract
Summary: A major translational barrier to the use of stem cell (SC)‐based therapy in patients with myocardial infarction (MI) is the lack of a clear understanding of the mechanism(s) underlying the cardioprotective effect of SCs. Numerous paracrine factors from SCs may account for reduction in infarct size, but myocardial salvage associated with transdifferentiation of SCs into vascular cells as well as cardiomyocyte‐like cells may be involved too. In this study, bone marrow‐derived rat mesenchymal SC (MSCs) were microencapsulated in alginate preventing viable cell release while supporting their secretory phenotype. The hypothesis on the key role of paracrine factors from MSCs in their cardioprotective activity was tested by comparison of the effect of encapsulated vs free MSCs in the rat model of MI. Intramyocardial administration of both free and encapsulated MSCs after MI caused reduction in scar size (12.1 ± 6.83 and 14.7 ± 4.26%, respectively, vs 21.7 ± 6.88% in controls, P = 0.015 and P = 0.03 respectively). Scar size was not different in animals treated with free and encapsulated MSC (P = 0.637). These data provide evidence that MSC‐derived growth factors and cytokines are crucial for cardioprotection elicited by MSC. Administration of either free or encapsulated MSCs was not arrhythmogenic in non‐infarcted rats. The consistency of our data with the results of other studies on the major role of MSC secretome components in cardiac protection further support the theory that the use of live, though encapsulated, cells for MI therapy may be replaced with heart‐targeted‐sustained delivery of growth factors/cytokines.Keywords
Funding Information
- Russian Foundation for Basic Research (18‐29‐02057)
This publication has 43 references indexed in Scilit:
- Cellular Encapsulation Enhances Cardiac RepairJournal of the American Heart Association, 2013
- Repairing chronic myocardial infarction with autologous mesenchymal stem cells engineered tissue in rat promotes angiogenesis and limits ventricular remodelingJournal of Biomedical Science, 2012
- Paracrine Mechanisms in Adult Stem Cell Signaling and TherapyCirculation Research, 2008
- Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repairBiomaterials, 2008
- Fibroblast Growth Factor-2 Regulates Myocardial Infarct RepairThe American Journal of Pathology, 2007
- Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarctionCardiovascular Research, 2007
- Direct Intramyocardial But Not Intracoronary Injection of Bone Marrow Cells Induces Ventricular Arrhythmias in a Rat Chronic Ischemic Heart Failure ModelCirculation, 2007
- Proarrhythmic Potential of Mesenchymal Stem Cell Transplantation Revealed in an In Vitro Coculture ModelCirculation, 2006
- Monitoring of Bone Marrow Cell Homing Into the Infarcted Human MyocardiumCirculation, 2005
- Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive LabelingCirculation, 2003